296 related articles for article (PubMed ID: 26905655)
21. Plant-based production of xenogenic proteins.
Hood EE; Jilka JM
Curr Opin Biotechnol; 1999 Aug; 10(4):382-6. PubMed ID: 10449314
[TBL] [Abstract][Full Text] [Related]
22. Expression and assembly of a fully active antibody in algae.
Mayfield SP; Franklin SE; Lerner RA
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):438-42. PubMed ID: 12522151
[TBL] [Abstract][Full Text] [Related]
23. Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.
Kapelski S; Boes A; Spiegel H; de Almeida M; Klockenbring T; Reimann A; Fischer R; Barth S; Fendel R
Malar J; 2015 Feb; 14():50. PubMed ID: 25651860
[TBL] [Abstract][Full Text] [Related]
24. Developments in the production of mucosal antibodies in plants.
Vasilev N; Smales CM; Schillberg S; Fischer R; Schiermeyer A
Biotechnol Adv; 2016; 34(2):77-87. PubMed ID: 26626615
[TBL] [Abstract][Full Text] [Related]
25. Production of monoclonal antibodies in plants for cancer immunotherapy.
Moussavou G; Ko K; Lee JH; Choo YK
Biomed Res Int; 2015; 2015():306164. PubMed ID: 26550566
[TBL] [Abstract][Full Text] [Related]
26. Bioproduction of human enzymes in transgenic tobacco.
Cramer CL; Weissenborn DL; Oishi KK; Grabau EA; Bennett S; Ponce E; Grabowski GA; Radin DN
Ann N Y Acad Sci; 1996 May; 792():62-71. PubMed ID: 8678421
[TBL] [Abstract][Full Text] [Related]
27. Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
Tsekoa TL; Lotter-Stark T; Buthelezi S; Chakauya E; Stoychev SH; Sabeta C; Shumba W; Phahladira B; Hume S; Morton J; Rupprecht CE; Steinkellner H; Pauly M; Zeitlin L; Whaley K; Chikwamba R
PLoS One; 2016; 11(7):e0159313. PubMed ID: 27427976
[TBL] [Abstract][Full Text] [Related]
28. Manufacturing plant-made monoclonal antibodies for research or therapeutic applications.
Swope K; Morton J; Pogue GP; Hume S; Pauly MH; Shepherd J; Simpson CA; Bratcher B; Whaley KJ; Zeitlin L; Davis KR; Haydon H
Methods Enzymol; 2021; 660():239-263. PubMed ID: 34742392
[TBL] [Abstract][Full Text] [Related]
29. Production of heterologous proteins in plants: strategies for optimal expression.
Desai PN; Shrivastava N; Padh H
Biotechnol Adv; 2010; 28(4):427-35. PubMed ID: 20152894
[TBL] [Abstract][Full Text] [Related]
30. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
[TBL] [Abstract][Full Text] [Related]
31. Controlled glycosylation of therapeutic antibodies in plants.
Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
[TBL] [Abstract][Full Text] [Related]
32. Reproducibility and flexibility of monoclonal antibody production with
Swope K; Morton J; Pogue GP; Burden L; Partain N; Hume S; Shepherd J; Simpson CA; Brennan MB; Furman TC; Kingrey-Gebe S; Martinez T; McDonough J; Pauly MH; Whaley KJ; Zeitlin L; Bratcher B; Haydon H
MAbs; 2022; 14(1):2013594. PubMed ID: 35000569
[TBL] [Abstract][Full Text] [Related]
33. Production, expression, and function of dual-specific monoclonal antibodies in a single plant.
Jin C; Kang YJ; Park SR; Oh YJ; Ko K
Planta; 2023 Dec; 259(1):15. PubMed ID: 38071691
[TBL] [Abstract][Full Text] [Related]
34. Production of antibodies in transgenic plants.
Larrick JW; Yu L; Chen J; Jaiswal S; Wycoff K
Res Immunol; 1998; 149(6):603-8. PubMed ID: 9835425
[TBL] [Abstract][Full Text] [Related]
35. Manufacturing antibodies in the plant cell.
Orzáez D; Granell A; Blázquez MA
Biotechnol J; 2009 Dec; 4(12):1712-24. PubMed ID: 20014227
[TBL] [Abstract][Full Text] [Related]
36. Advances and challenges in the development and production of effective plant-based influenza vaccines.
Yusibov V; Kushnir N; Streatfield SJ
Expert Rev Vaccines; 2015 Apr; 14(4):519-35. PubMed ID: 25487788
[TBL] [Abstract][Full Text] [Related]
37. Potential application of Leishmania tarentolae as an alternative platform for antibody expression.
Lai JY; Klatt S; Lim TS
Crit Rev Biotechnol; 2019 May; 39(3):380-394. PubMed ID: 30720351
[TBL] [Abstract][Full Text] [Related]
38. [Plants as an alternative source of therapeutic proteins].
Łucka M; Kowalczyk T; Szemraj J; Sakowicz T
Postepy Hig Med Dosw (Online); 2015 Mar; 69():362-73. PubMed ID: 25811472
[TBL] [Abstract][Full Text] [Related]
39. Recombinant plasma proteins.
Burnouf T
Vox Sang; 2011 Jan; 100(1):68-83. PubMed ID: 21175657
[TBL] [Abstract][Full Text] [Related]
40. Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.
da Cunha NB; Vianna GR; da Almeida Lima T; Rech E
Biotechnol J; 2014 Jan; 9(1):39-50. PubMed ID: 24376137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
